These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 37116624)
21. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics. Pazianas M; Miller PD Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081 [TBL] [Abstract][Full Text] [Related]
22. Trabecular bone score may indicate chronic kidney disease-mineral and bone disorder (CKD-MBD) phenotypes in hemodialysis patients: a prospective observational study. Yun HJ; Ryoo SR; Kim JE; Choi YJ; Park I; Shin GT; Kim H; Jeong JC BMC Nephrol; 2020 Jul; 21(1):299. PubMed ID: 32711466 [TBL] [Abstract][Full Text] [Related]
23. Development of a quantitative systems pharmacology model of chronic kidney disease: metabolic bone disorder. Gaweda AE; McBride DE; Lederer ED; Brier ME Am J Physiol Renal Physiol; 2021 Feb; 320(2):F203-F211. PubMed ID: 33308018 [TBL] [Abstract][Full Text] [Related]
24. Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters. Roetker NS; Peng Y; Ashfaq A; Gilbertson DT; Wetmore JB Am J Nephrol; 2019; 49(3):225-232. PubMed ID: 30820015 [TBL] [Abstract][Full Text] [Related]
25. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
26. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD. Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713 [TBL] [Abstract][Full Text] [Related]
27. Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function . Nowak KL; Hung A; Ikizler TA; Farmer-Bailey H; Salas-Cruz N; Sarkar S; Hoofnagle A; You Z; Chonchol M Clin Nephrol; 2017 Sep; 88(9):132-143. PubMed ID: 28699886 [TBL] [Abstract][Full Text] [Related]
28. Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis. Yamada S; Tsuruya K; Kitazono T; Nakano T Clin Exp Nephrol; 2022 Jul; 26(7):613-629. PubMed ID: 35353283 [TBL] [Abstract][Full Text] [Related]
30. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis. Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472 [TBL] [Abstract][Full Text] [Related]
31. A rat model of chronic kidney disease-mineral bone disorder. Moe SM; Chen NX; Seifert MF; Sinders RM; Duan D; Chen X; Liang Y; Radcliff JS; White KE; Gattone VH Kidney Int; 2009 Jan; 75(2):176-84. PubMed ID: 18800026 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce. Bacchetta J; Schmitt CP; Bakkaloglu SA; Cleghorn S; Leifheit-Nestler M; Prytula A; Ranchin B; Schön A; Stabouli S; Van de Walle J; Vidal E; Haffner D; Shroff R Pediatr Nephrol; 2023 Sep; 38(9):3163-3181. PubMed ID: 36786859 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria. Okoye JU; Arodiwe EB; Ulasi II; Ijoma CK; Onodugo OD Afr Health Sci; 2015 Sep; 15(3):941-8. PubMed ID: 26957985 [TBL] [Abstract][Full Text] [Related]
34. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome]. Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009 [TBL] [Abstract][Full Text] [Related]
35. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V; Torregrosa V Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742 [TBL] [Abstract][Full Text] [Related]
36. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis. Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817 [TBL] [Abstract][Full Text] [Related]
37. Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model. Mohamed FF; Amadeu de Oliveira F; Kinoshita Y; Yalamanchili RR; Eltilib LA; Andras NL; Narisawa S; Tani T; Chu EY; Millán JL; Foster BL J Bone Miner Res; 2023 Aug; 38(8):1192-1207. PubMed ID: 37191192 [TBL] [Abstract][Full Text] [Related]
38. CKD-MBD biomarkers and CKD progression: an analysis by the joint model. D'Arrigo G; Mallamaci F; Pizzini P; Leonardis D; Tripepi G; Zoccali C Nephrol Dial Transplant; 2023 Mar; 38(4):932-938. PubMed ID: 35790138 [TBL] [Abstract][Full Text] [Related]
39. Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients. Hasparyk UG; Vigil FMB; Bartolomei VS; Nunes VM; Simões E Silva AC Curr Med Chem; 2022 Aug; 29(31):5230-5253. PubMed ID: 35306980 [TBL] [Abstract][Full Text] [Related]
40. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ; Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]